prostate cancer: what’s the difference between hereditary and biomarker testing?
Published 1 year ago • 6 plays • Length 3:48Download video MP4
Download video MP3
Similar videos
-
2:38
what is a prostate cancer biomarker?
-
5:10
how do biomarker test results impact prostate cancer treatment options?
-
3:08
targeted prostate cancer therapies vs. chemotherapy: what’s the difference?
-
1:35
how do biomarker test results impact a prostate cancer patient’s prognosis?
-
5:34
what is the difference between genetic and biomarker testing?
-
6:45
how is advanced prostate cancer treatment personalized?
-
8:39
role of biomarkers in metastatic prostate cancer
-
7:15
optimizing biomarker testing for patients with metastatic prostate cancer
-
42:44
biomarkers and prostate cancer
-
33:23
advances in biomarker testing - summit 2021
-
25:16
episode 2: navigating biomarker testing and treatment for patients with prostate cancer
-
40:22
biomarkers: psa, 4k, or phi?
-
1:00:45
science cafe - prostate cancer - biomarkers, prevention strategies, and treatment innovations
-
0:59
what is prostate and prostate cancer? - dr michael a. jenkins
-
1:12
prognostic biomarkers for prostate cancer
-
5:50
how is biomarker testing carried out?
-
1:03
how common is prostate cancer? penn state cancer institute
-
21:10
episode 1: debunking myths and reinforcing the value of biomarker testing in prostate cancer
-
10:56
biomarkers in the management of prostate cancer